CNTX   $2.205  12.50% Market Closed After Close 2.37 7.48%

Context Therapeutics Inc
Total Cash 101.54M
totalCashPerShare 1.354
EBITDA -20.01M
Total Debt 0.00
quickRatio 63.289
currentRatio 64.013
Total Revenue
debtToEquity
Revenue/Share
ROA -0.19186
ROE -0.29681
grossProfits
freeCashflow -12.33M
operatingCashflow -18.40M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 55.21M
forwardPE -7.172414
floatShares 39.07M
sharesOutstanding 75.00M
sharesShort 1.77M
sharesShortPriorMonth 2.02M
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.03%
heldPercentInstitutions 0.78%
Short Ratio help_outline 20.91%
shortPercentOfFloat 0.03%
impliedSharesOutstanding
bookValue 1.348
Price To Book help_outline 1.54
earningsQuarterlyGrowth
netIncomeToCommon -18.57M
trailingEps -0.96%
forwardEps -0.29%
enterpriseToEbitda -2.76
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.04 3Q 2024
institutionsCount 39
lastUpdated Sept. 16, 2024, 8:30 p.m.